News | Proton Therapy | April 05, 2016

New-generation IBA Proteus One Accelerator Receives CE Mark

Centre Antoine-Lacassagne (CAL) in Nice ready to treat patients soon

IBA, Proteus One, accelerator, proton therapy, Centre Antoine-Lacassagne, France

April 5, 2016 — IBA (Ion Beam Applications SA) has recently received CE mark authorization of its new supra conducting accelerator. The accelerator is the latest development of the Proteus One, IBA’s compact intensity modulated proton therapy (IMPT) system, that needed approval from competent authorities.
 
CE Marking was a necessary step towards the acceptance of the first Proteus One in Europe, which is located at the Centre Antoine-Lacassagne (CAL) in Nice, France. In less than three months, in June 2016, the center will be fully accepted with all necessary certifications.  
 
IBA has signed another five additional contracts to provide Proteus One in Europe, with a total of 12 centers sold worldwide.
 
For more information: www.iba-worldwide.com

Related Content

Stronger Distribution Networks to Bolster Radiotherapy Patient Positioning Accessories
News | Patient Positioning Radiation Therapy | July 19, 2019
A recent study projects global market revenues for radiotherapy patient positioning accessories will exceed revenues of...
CMS Proposes New Alternative Payment Model for Radiation Oncology
News | Radiation Oncology | July 17, 2019
The Centers for Medicare and Medicaid Services (CMS) issued a proposal for an advanced alternative payment model (APM)...
AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...
RaySearch Releases Version 3A of RayCare Oncology Information System
Technology | Oncology Information Management Systems (OIMS) | July 15, 2019
RaySearch has released RayCare 3A, a new version of the next-generation oncology information system (OIS). RayCare is...
IBA Launches Monte Carlo Patient QA for Varian Halcyon at AAPM 2019
Technology | Quality Assurance (QA) | July 10, 2019
IBA announced the launch of the latest functionality of the SciMoCa Monte Carlo Patient QA solution at the 61st annual...
Researchers Use Artificial Intelligence to Deliver Personalized Radiation Therapy
News | Radiation Therapy | July 09, 2019
New Cleveland Clinic-led research shows that artificial intelligence (AI) can use medical scans and health records to...
The Beamscan 3-D water phantom with the Varian Halcyon radiotherapy system

The Beamscan 3-D water phantom with the Varian Halcyon radiotherapy system. Image courtesy of PTW.

News | Quality Assurance (QA) | July 08, 2019
At this year’s American Association of Physicists in Medicine (AAPM) show, July 14-18 in San Antonio, Texas, PTW will...